Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iridex (IRIX) Research & Development (2016 - 2025)

Iridex (IRIX) has 16 years of Research & Development data on record, last reported at $972000.0 in Q3 2025.

  • For Q3 2025, Research & Development fell 25.17% year-over-year to $972000.0; the TTM value through Sep 2025 reached $3.8 million, down 36.45%, while the annual FY2024 figure was $5.4 million, 20.21% down from the prior year.
  • Research & Development reached $972000.0 in Q3 2025 per IRIX's latest filing, up from $871000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $4.5 million in Q1 2022 and bottomed at $871000.0 in Q2 2025.
  • Average Research & Development over 5 years is $1.6 million, with a median of $1.5 million recorded in 2024.
  • The widest YoY moves for Research & Development: up 81.63% in 2022, down 67.58% in 2022.
  • A 5-year view of Research & Development shows it stood at $1.2 million in 2021, then rose by 24.46% to $1.4 million in 2022, then rose by 16.83% to $1.7 million in 2023, then crashed by 34.3% to $1.1 million in 2024, then fell by 12.67% to $972000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $972000.0 in Q3 2025, $871000.0 in Q2 2025, and $876000.0 in Q1 2025.